Genotypic-resistance assays and antiretroviral therapy

Lancet. 1997 May 24;349(9064):1489-90. doi: 10.1016/S0140-6736(05)62092-2.
No abstract available

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Codon / genetics
  • Costs and Cost Analysis
  • Drug Resistance, Microbial / genetics
  • Genome, Viral
  • Genotype
  • HIV / genetics*
  • HIV Infections / drug therapy*
  • Humans
  • Microbial Sensitivity Tests / economics
  • Microbial Sensitivity Tests / methods
  • Mutation / genetics
  • Predictive Value of Tests
  • Protease Inhibitors / therapeutic use
  • Virus Replication / genetics

Substances

  • Anti-HIV Agents
  • Codon
  • Protease Inhibitors